Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Documenti

No. 51 (2018)

Protocollo per la presa in carico di pazienti a doppia diagnosi

Submitted
aprile 19, 2019
Published
2019-04-19

References

  1. Babor T., Campbel R., Room R. et al. (1994). Lexicon of alcohol and drug terms. Geneva: World Health Organization.
  2. Carrà G., Crocamo G., Borrelli P., Popa I., Ornaghi A., Montomoli C., Clerici M. (2015). Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders Findings from the “Psychiatric and Addictive
  3. Dual Disorder in Italy (PADDI)” Study. Comprehensive Psychiatry, 58: 152-159.
  4. Clerici M., Carta I., Cazzullo C.L. (1989). Substance abuse and psychopathology. A diagnostic screening of Italian narcotic addicts. Soc Psychiatry Psychiatr Epidemiol, 24: 219-26.
  5. Di Petta G. (2017). Clinica del paziente con schizofrenia che usa o ha usato sostanze: il ruolo dei LAI. Convegno “Oltre la doppia diagnosi”, Milano, 19 aprile.
  6. Drake R.E., Essock S.M., Shaner A. et al. (2001). Implementing sual siagnosis services for clients with severe mental illness. Psychiatr Serv., 52: 469-476.
  7. Giampieri E., Alamia A., Galimberti G.L., Tinghino B., Resentini M., Clerici M. (2013). “Doppia diagnosi” e consumo di risorse sanitarie nel DSM. L’esperienza di Monza e Brianza. “Dual diagnosis” and use of healthcare resources in psychiatric care services. The experience of Monza and Brianza. Journal of Psychopathology.
  8. Grant F.B. (1996). Prevalence and correlates of drug use and DSMIV drug dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse, 8: 195-210.
  9. Kessler R.C., McGonagle K.A., Zhao S. et al. (1996). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry, 1994, 51: 8-19.
  10. Meyer R.E. (1986). Psychopathology and addictive disorders. New York: The Guilford Press.
  11. Morojele N.K., Saban A., Seedat S. (2012). Clinical presentations and diagnostic issues in dual diagnosis disorders. Curr Opin Psychiatry, 25: 181-6.
  12. Niemi-Pynttaeri J.A. et al. (2013). Substance induced psychosis converting into schizophrenia: a register-based study of 18478 Finnish inpatient cases. J. Clin. Psychiatry, 74: e94-9.
  13. Pani P.P., Carta M., Rudas N. (1991). Psychopathological heterogeneity in opium drug addicts. Minerva Psichiatr, 32: 145-50.
  14. Regier D.A., Farmer M.E., Rae D.S. et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA, 264: 2511-8.
  15. Rockville M.D. (2005). Substance abuse treatment for persons with cooccurring disorders. Center for Substance Abuse Treatment. Substance Abuse and Mental Health Services Administration.
  16. Tempesta E., Pozzi G., Tacchini G. et al. (1995). Mental disorders of drug addicts in treatment: a study of prevalence with retrospective evaluation by means of structured diagnostic interviews. Minerva Psichiatr, 36: 139-54.
  17. Verde L., Moccia E., Riccio M. et al. (2010). Oltre la doppia diagnosi: la gestione del paziente multiproblematico nel Servizio per le Tossicodipendenze. Case management e lavoro di rete in un caso clinico. Mission, 31: 19-24.

Metrics

Metrics Loading ...